{"id":"W2898792243","doi":"10.3851/imp3278","title":"Daclatasvir and Sofosbuvir with Ribavirin for 24 Weeks in Chronic Hepatitis C Genotype-3-Infected Patients with Cirrhosis: A Phase III Study (ALLY-3C)","year":2018,"lang":"en","type":"article","venue":"Antiviral Therapy","topic":"Hepatitis C virus research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Paul's Hospital; Toronto General Hospital; University of Toronto; Regina General Hospital; University of Alberta; University of Saskatchewan; Research Canada","funders":"Daiichi Sankyo Europe; Gilead Sciences; Pfizer; Daiichi-Sankyo; Bristol-Myers Squibb","keywords":"Sofosbuvir; Daclatasvir; Ribavirin; Medicine; Internal medicine; Cirrhosis; Hepatitis C; Gastroenterology; Clinical endpoint; Adverse effect; Hepatitis C virus; Virology; Clinical trial; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004560283,0.001388565,0.002047461,0.0004462403,0.0005442399,0.0007552804,0.000690654,0.001237115,0.00238137],"category_scores_gemma":[0.001660436,0.0005795156,0.00177965,0.0006105775,0.001062242,0.0006411872,0.0004601034,0.002175353,0.0004501283],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009255996,"about_ca_system_score_gemma":0.002605094,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002000553,"about_ca_topic_score_gemma":0.002827802,"domain_scores_codex":[0.9985814,0.0008942005,0.00007525555,0.0001097336,0.0001304713,0.0002089469],"domain_scores_gemma":[0.9981707,0.0003125386,0.0002799505,0.0001362656,0.0001548549,0.0009456209],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8335558,0.0694695,0.01694826,0.0007383475,0.001618706,0.0001925152,0.0002736097,0.001333878,0.01254287,0.0001141399,0.001372185,0.06184014],"study_design_scores_gemma":[0.6978794,0.2842999,0.01481567,0.00003534805,0.0003730735,0.0001703989,0.00004578402,0.0006618794,0.0009702275,0.00005414602,0.0006722008,0.00002195417],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963635,0.001495457,0.0002112707,0.0001964776,0.00005206233,0.0009586026,0.0002494394,0.00003070058,0.000442517],"genre_scores_gemma":[0.9923179,0.001295023,0.001800737,0.0005908435,0.0001793074,0.001907633,0.00107581,0.00001719834,0.0008154588],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004560283,"threshold_uncertainty_score":0.02411735,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02779111316162918,"score_gpt":0.3371077543208006,"score_spread":0.3093166411591714,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}